Zhaoping Yan

418 total citations
17 papers, 363 citations indexed

About

Zhaoping Yan is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, Zhaoping Yan has authored 17 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Biochemistry. Recurrent topics in Zhaoping Yan's work include Inflammatory mediators and NSAID effects (8 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Zhaoping Yan is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Zhaoping Yan collaborates with scholars based in United States, China and Canada. Zhaoping Yan's co-authors include Philip P. Stapleton, J.M. Daly, Babette B. Weksler, Andrew J. Dannenberg, Fan Zhang, Timothy A. McCaffrey, Tadashi Tanabe, Tura C. Camilli, Kotha Subbaramaiah and Jinhang Gao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Zhaoping Yan

17 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoping Yan United States 12 118 78 67 65 62 17 363
Ajeeth K. Pingili United States 13 107 0.9× 39 0.5× 59 0.9× 37 0.6× 89 1.4× 18 348
Marchele Nowell United States 7 127 1.1× 75 1.0× 63 0.9× 44 0.7× 44 0.7× 7 366
Lise Sofie Haug Nissen‐Meyer Norway 12 211 1.8× 72 0.9× 42 0.6× 36 0.6× 67 1.1× 37 565
Irvith M. Carvajal United States 10 228 1.9× 49 0.6× 93 1.4× 43 0.7× 37 0.6× 13 419
René HM te Morsche Netherlands 8 93 0.8× 102 1.3× 31 0.5× 52 0.8× 49 0.8× 9 336
Vany Nascimento-Silva Brazil 9 154 1.3× 73 0.9× 82 1.2× 42 0.6× 15 0.2× 10 427
Minjuan Fu United States 8 98 0.8× 69 0.9× 82 1.2× 41 0.6× 17 0.3× 9 403
Tetsuro Hiratsuka Japan 15 90 0.8× 185 2.4× 59 0.9× 38 0.6× 57 0.9× 26 474
Thomas Bärnthaler Austria 12 183 1.6× 71 0.9× 90 1.3× 28 0.4× 29 0.5× 30 517
Jaewoong Jang South Korea 10 181 1.5× 31 0.4× 72 1.1× 43 0.7× 37 0.6× 18 377

Countries citing papers authored by Zhaoping Yan

Since Specialization
Citations

This map shows the geographic impact of Zhaoping Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoping Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoping Yan more than expected).

Fields of papers citing papers by Zhaoping Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoping Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoping Yan. The network helps show where Zhaoping Yan may publish in the future.

Co-authorship network of co-authors of Zhaoping Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoping Yan. A scholar is included among the top collaborators of Zhaoping Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoping Yan. Zhaoping Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yan, Zhaoping, et al.. (2018). Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis. Medicine. 97(31). e11716–e11716. 7 indexed citations
2.
Spreafico, Anna, Michael B. Sawyer, Lillian L. Siu, et al.. (2018). Effects of rifampin on the pharmacokinetics of copanlisib, a novel pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor in cancer patients.. Journal of Clinical Oncology. 36(15_suppl). e14559–e14559. 1 indexed citations
3.
Gao, Jinhang, Shilei Wen, Huan Tong, et al.. (2017). Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride. Molecular Medicine Reports. 15(4). 1507–1512. 26 indexed citations
4.
Yan, Zhaoping, Yile Huang, Xiangyun Chen, et al.. (2017). Study of natural IgG antibodies against vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.. PubMed. 7(3). 603–609. 6 indexed citations
5.
Tong, Huan, Yang Tai, Hao Wu, et al.. (2017). Carbohydrate antigen 125 and carcinoembryonic antigen in the differentiation of tuberculous peritonitis and peritonitis carcinomatosa. Oncotarget. 8(44). 78068–78075. 8 indexed citations
6.
Wen, Shilei, Feng Shi, Jinhang Gao, et al.. (2016). Collapsed Reticular Network and its Possible Mechanism during the Initiation and/or Progression of Hepatic Fibrosis. Scientific Reports. 6(1). 35426–35426. 17 indexed citations
7.
Yan, Zhaoping, Jinhang Gao, Xiu‐He Lv, et al.. (2016). Quantitative Evaluation and Selection of Reference Genes for Quantitative RT-PCR in Mouse Acute Pancreatitis. BioMed Research International. 2016. 1–11. 27 indexed citations
8.
Lv, Xiu‐He, Chunhui Wang, Yan Xie, & Zhaoping Yan. (2015). Diagnostic Efficacy of Magnifying Endoscopy with Narrow-Band Imaging for Gastric Neoplasms: A Meta-Analysis. PLoS ONE. 10(4). e0123832–e0123832. 14 indexed citations
9.
Maddali, Sirish, Philip P. Stapleton, Zhaoping Yan, et al.. (2004). Altered cyclooxygenase-2 expression and nitric oxide metabolism following major elective surgery. Journal of Surgical Research. 116(2). 211–218. 5 indexed citations
10.
Maddali, Sirish, Philip P. Stapleton, Gordon K. Smyth, et al.. (2004). Neuroendocrine responses mediate macrophage function after trauma. Surgery. 136(5). 1038–1046. 13 indexed citations
11.
Yan, Zhaoping, et al.. (2004). Enhanced expression of cyclooxygenase-2 and prostaglandin E2 in response to endotoxin after trauma is dependent on MAPK and NF-κB mechanisms. Cellular Immunology. 232(1-2). 116–126. 31 indexed citations
12.
Stapleton, Philip P., et al.. (2004). Gender affects macrophage cytokine and prostaglandin E2 production and PGE2 receptor expression after trauma1. Journal of Surgical Research. 122(1). 1–7. 22 indexed citations
13.
Duff, Michael, Philip P. Stapleton, Juan Mestre, et al.. (2003). Cyclooxygenase-2 Inhibition Improves Macrophage Function in Melanoma and Increases the Antineoplastic Activity of Interferon ?. Annals of Surgical Oncology. 10(3). 305–313. 18 indexed citations
14.
Smyth, Gordon K., Philip P. Stapleton, Catherine B. Barden, et al.. (2003). Renal Cell Carcinoma Induces Prostaglandin E2 and T-Helper Type 2 Cytokine Production in Peripheral Blood Mononuclear Cells. Annals of Surgical Oncology. 10(4). 455–462. 37 indexed citations
15.
Strong, Vivian E., Jordan M. Winter, Zhaoping Yan, et al.. (2001). Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury. Surgery. 130(2). 249–255. 20 indexed citations
16.
Yan, Zhaoping, Kotha Subbaramaiah, Tura C. Camilli, et al.. (2000). Benzo[a]pyrene Induces the Transcription of Cyclooxygenase-2 in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 275(7). 4949–4955. 99 indexed citations
17.
Yan, Zhaoping, Gloria Y. Lee, & Everett Anderson. (1997). Influence of Dehydroepiandrosterone on the Expression of Insulin-Like Growth Factor-1 during Cystogenesis in Polycystic Rat Ovaries and in Cultured Rat Granulosa Cells1. Biology of Reproduction. 57(6). 1509–1516. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026